Evolving therapies for atopic dermatitis: Bridging guidelines and practice
| Autor: | Pawinee Rerknimitr |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Annals, Academy of Medicine, Singapore, Vol 53, Iss 11, Pp 641-643 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2972-4066 26992728 |
| DOI: | 10.47102/annals-acadmedsg.2024355 |
| Popis: | Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition characterised by dysregulated type 2 immune responses, skin barrier dysfunction and intense pruritus (itching). The disease burden of AD is substantial, affecting at least 171 million individuals worldwide in 2019, representing 2.23% of the global population.1 Among skin diseases, AD ranks highest in disease burden, as measured by disability-adjusted life-years (DALYs).2 Its profound impact on patients’ quality of life, along with significant economic burdens, underscores its status as a major healthcare challenge. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|